MedPath

VIVATECH INTERNATIONAL, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
3 (100.0%)

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee

Phase 2
Recruiting
Conditions
Osteoarthritis
First Posted Date
2016-07-26
Last Posted Date
2023-08-07
Lead Sponsor
VivaTech International, Inc.
Target Recruit Count
4000
Registration Number
NCT02844751
Locations
🇺🇸

VivaTech International, Inc., Grove City, Pennsylvania, United States

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder

Phase 2
Recruiting
Conditions
Osteoarthritis
First Posted Date
2016-07-26
Last Posted Date
2023-08-07
Lead Sponsor
VivaTech International, Inc.
Target Recruit Count
4000
Registration Number
NCT02844738
Locations
🇺🇸

VivaTech International, Inc., Grove City, Pennsylvania, United States

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip

Phase 2
Recruiting
Conditions
Osteoarthritis
First Posted Date
2016-07-26
Last Posted Date
2023-08-07
Lead Sponsor
VivaTech International, Inc.
Target Recruit Count
4000
Registration Number
NCT02844764
Locations
🇺🇸

VivaTech International, Inc., Grove City, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.